ARGENT BIOPHARMA Stock Price, News & Analysis
Company Description
ARGENT BIOPHARMA (OTC: MGCLF) is a publicly traded medicinal and botanical manufacturing company in the Manufacturing sector.
MGCLF stock has declined 91.5% over the past year. Shares last traded at $0.2675.
This page provides a comprehensive overview of MGCLF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
ARGENT BIOPHARMA (MGCLF) stock last traded at $0.2675. Over the past 12 months, the stock has lost 91.5%.
Latest News
ARGENT BIOPHARMA has 4 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 3 with negative movement. Key topics include partnership. View all MGCLF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MGCLF Company Profile & Sector Positioning
ARGENT BIOPHARMA (MGCLF) operates in the Medicinal and Botanical Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.